Results50 per page · sorted by obligated FY2024+
| Award | Company | Obligated FY2024+ | What | Agency | Category | Latest action |
|---|---|---|---|---|---|---|
| W81XWH20C0030 definitive contract | Cellphire, Inc | $49.4M | Cryopreserved platelet (cpp) development for us fda licensure | Defense Health Agency | Health R&D | Apr 14, 2026 DoD 90d |
| W81XWH20C0077 definitive contract | Applied Research Associates, Inc | $499K | Jw190523 fy19 new start | Defense Health Agency | Health R&D | Mar 11, 2025 DoD 90d |
| W81XWH20C0115 definitive contract | Neurowave Systems Inc | $0 | Sbir phase iii: jw190526 | Army | Health R&D | Nov 25, 2024 DoD 90d |
| W81XWH20C0142 definitive contract | Philips North America LLC | $0 | Proposal log no. dm190207, portable device for rapid vascular access in trauma and hemorrhage control | Defense Health Agency | Health R&D | Jun 1, 2026 DoD 90d |
| W81XWH20C0039 definitive contract | University of Southern California | -$4.5K | Jw190476 fy19 new start | Defense Health Agency | Health R&D | Apr 29, 2025 DoD 90d |
| W81XWH20C0066 definitive contract | Ophirex, Inc | -$645K | Covid-19 DHA 2018.1 sbir phase iii medical R&D contract proposal titled: "targeting spla2 for treatment of acute respiratory distress syndrome (ards) associated with sars-cov-2" log #19000053 | Defense Health Agency | Health R&D | Sep 5, 2025 DoD 90d |
Source: USAspending.gov prime award data (FPDS), DoD and DHS contracts, orders and IDVs with any action since Oct 1, 2023. Obligated FY2024+ sums the obligations on those actions; total obligated is the award's lifetime figure. DoD contract actions publish on USAspending about 90 days after signing (DFARS PGI 204.6), so the latest DoD actions here trail the calendar by about 3 months. Data as of Oct 9, 2026.
Terminal: filters by company, agency, category and date, with CSV export.
7 days free for first-time subscribers, then $49/mo. Card required. Cancel before day 8 and you pay nothing.
Start free trial